Page 320 - ILAE_Lectures_2015
P. 320

16. LIVINGSTON, J.H., BEAUMONT, D., ARZIMANOGLOU, A. et al (1989) Vigabatrin in the treatment of epilepsy
       in children. Br J Clin Pharm 27 (suppl), 109-112.

17 DULAC, O., CHIRON, C., LUNA, D. et al (1991) Vigabatrin in childhood epilepsy. J Child Neurol 6 (suppl), 2S30-
       S237.

18. GIBBS, J., APPLETON, R.E. and ROSENBLOOM, L. (1992) Vigabatrin in intractable childhood epilepsy: a
       retrospective study. Pediatr Neurol 8, 338-340.

19. APPLETON, R.E. (1993) The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 43,
       2l-23.

20. CURATOLO, P. (l994) Vigabatrin for refractory partial seizures in children with tuberous sclerosis. Neuropediatrics
       25, 55.

21. EKE, T., TALBOT, J.F. and LAWDEN, M.C. (1997) Severe, persistent visual field constriction associated
       with vigabatrin. Br Med J 314, l80-l8l.

22. VANHATALO, S., NOUSIAINEN, I., ERIKSSON, K. et al. (2002) Visual field constriction in 91 Finnish
       children treated with vigabatrin. Epilepsia 43, 748-756.

23. APPLETON, R.E., FICHTNER, K., MURRAY, G. et al (1999) Gabapentin as add-on therapy in children with
       refractory partial seizures: a l2-week multicentre, double-blind, placebo-controlled study. Epilepsia 40, 1147-1154.

24. KHURANA, D.S., RIVIELLO, J., HELMERS, S. et al (1996) Efficacy of gabapentin therapy in children with
       refractory partial seizures. J Pediatr 128, 829-833.

25. APPLETON, R.E., FICHTNER, K., LAMOREAUX, L. et al (2001) Gabapentin as add-on therapy in children with
       refractory partial seizures: a 24-week, multicentre, open-label study. Dev Med Child Neurol 43, 269-273.

26. UK Gabapentin Study Group (1990) Gabapentin in partial epilepsy. Lancet 335, 1114-1117.
27. US Gabapentin Study Group (1993) Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind,

       placebo-controlled, parallel group study. Neurology 43, 2292-2298.
28. TRUDEAU, V., MYERS, S., LaMOREAUX, L. et al (1996) Gabapentin in naive childhood absence epilepsy: results

       from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 11, 470-475.
29. GLAUSER, T.A. (1997) Topiramate. Semin Pediatr Neurol 4, 34-42.
30. GLAUSER, T.A. (1998) Topiramate use in pediatric patients. Can J Neurol Sci 25, S8-S12.
31. MORELAND, E.C., GRIESEMER, D.A., HOLDEN, K.R. (1999) Topiramate for intractable childhood epilepsy.

       Seizure 8, 38-40.
32. SACHDEO, R., KUGLER, S., WENGER, E. et al (1996) Topiramate in Lennox-Gastaut syndrome. Epilepsia 37

       (suppl 4), 118-119.
33. WHELESS, J.W., NETO, W., WANG, S. et al (2004) Topiramate, carbamazepine and valproate monotherapy:

       double-blind comparison in children with newly diagnosed epilepsy J Child Neurol 19, 135-141.
34. MOHAMED, K., APPLETON, R.E. and ROSENBLOOM, L. (2000) Efficacy and tolerability of topiramate in

       childhood and adolescent epilepsy: a clinical experience. Seizure 9, 137-141.
35 LEACH, J.P. and BRODIE, M.J. (1998) Tiagabine. Lancet 351, 203-207.
36. BEN-MENACHEM, E. (1995) International experience with tiagabine add-on therapy. Epilepsia 36, 14-2l.
37 KELLINGHAUS, C., DZIEWAS, R. and LUDEMAN, P. (2002) Tiagabine-related non-convulsive status

       epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 11, 242-249.
38. SKARDOUTSOU, A., VOUDRIS, K.A. and VAGIAKOU, E.A. (2003) Non-convulsive status epilepticus

       associated with tiagabine therapy in children Seizure 12, 599-601.
39. GELISSE, P., GENTON, P., KUATE, C. et al (2004) Worsening of seizures by oxcarbazepine in juvenile idiopathic

       epilepsies. Epilepsia 45, 1282-1286.
40. LEPPIK, I.E., DREIFUSS, F.E., PLEDGER, G.W. et al (1991) Felbamate for partial seizures: Results of a controlled

       clinical trial. Neurology 41, 1785-1789.
41. THEODORE, W.H., RAUBERTAS, R.F., PORTER, J.R. et al (1991) Felbamate: A clinical trial for complex partial

       seizures. Epilepsia 32, 392-397.
42. DEVINSKY, O., VAZQUEZ, B. and LUCIANO, D. (1994) New antiepileptic drugs for children: felbamate,

       gabapentin, lamotrigine and vigabatrin. J. Child Neurol 9 (suppl), S33-S45.
43 The Felbamate Study Group in Lennox-Gastaut Syndrome (1993) Efficacy of felbamate in childhood epileptic

       encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 328, 29-33.
44. BAULAC, M. (2006) Introduction to zonisamide. Epilepsy Res 68 (suppl 2), S3-S9.
45. ZAREBA, G. (2005) Zonisamide: review of its use in epilepsy therapy. Drugs Today 41, 589-597.
46. GLAUSER, T., KLUGER, G., SACHDEO, R. et al (2008) Rufinamide for generalised seizures associated with

        Lennox Gastaut syndrome Neurology 70, 1950-1958.
47. FORSYTHE, W.I., OWENS, J.R. and TOOTHILL, C. (1981) Effectiveness of acetazolamide in the treatment of

       carbamazepine  resistant epilepsy in children. Dev Med Child Neurol 23, 761-769.
48. BLENNOW, G. and STARCK, L. (1986) High dose B6 treatment in infantile spasms. Neuropediatrics 17, 7-10.
49. CLAYTON, P.T. (2006) B6 responsive disorders: a model of vitamin dependency. J Inherit Metab Dis 29, 317-326.
50. CROSS, J.H. (2010) Dietary therapies – an old idea with a new lease of life. Seizure 19, 671-674.
51. GUPTA, R. and APPLETON, R. (2005) Corticosteroids in the management of the paediatric epilepsies. Arch Dis

       Child 90, 379-384.
52 ARIIZUMI, M., BABA, K., HIBIO, S. et al (1987) Immuno-globulin therapy in the West syndrome. Brain Dev 9,

       422-425.
53. ECHENNE, B., DULAC, O., PARAYRE-CHANEZ, M.J. et al (1991) Treatment of infantile spasms with

       intravenous gamma-globulins. Brain Dev 13, 313-319.
54. BEDINI, R., DE FEO, M.R., ORANO, A. et al (1985) Effects of gamma globulin therapy in severely epileptic

       children. Epilepsia 26, 98-102.
55. GROSS-TSUR, V., SHALEV, R.S., KAZIR, E. et al (1993) Intravenous high-dose gammaglobulins for intractable

       childhood epilepsy. Acta Neurol Scand 88, 204-209.
   315   316   317   318   319   320   321   322   323   324   325